You have been selected to receive this newsletter based on your interest in learning more about gene therapy viral vectors. It contains some of our most popular viral vector related content. Read on and let us help you advance your research.
Sponsored by
BPS Bioscience strives to advance new scientific discoveries that lead to therapies by creating innovative and novel solutions for drug discovery research.
Integration-deficient recombinant AAV are used in gene therapy to deliver a gene of interest (up to =5 kb in length) in place of the viral genome. Due to its ...
Download »
Lentivirus transduction has distinct advantages over gene delivery methods. Due to its high rate of infection, lentivirus transduction tends to be more ...
Download »
The Firefly Luciferase-eGFP Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase and ... More »
You received this email because you are subscribed
to our database. Need to change your settings?
Email Settings
or Unsubscribe here
